Brought to you by 
Series F financing brings £25mm to Oxford Nanopore Technologies
06 Jun 2011
Executive Summary
Oxford Nanopore Technologies Ltd. (formerly Oxford NanoLabs; single-molecule DNA sequencing and protein analysis) has raised £25mm ($41mm) in what is assumed to be its Series F round. Returning and first-time institutional and individual investors based in the UK and US participated, including Lansdowne Partners, seed backer IP Group, Invesco Perpetual, Redmile Group, and the company’s strategic partner Illumina. Taking into account the new financing, Oxford has accumulated £74mm to date.
Deal Industry
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series F financing brings £25mm to Oxford Nanopore Technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice